CORRECTING and REPLACING – Gemphire Therapeutics Enrolls First Patients in the ROYAL-1 Trial Investigating Gemcabene in ...
ROYAL-1 is a Phase 2b Study to Determine Safety and Tolerability of Gemcabene in Hypercholesterolemia Not Adequately Controlled on High-Intensity or Moderate-Intensity Stable Statin Therapy Topline Data Readout Anticipated in Second Half 2017 LIVONIA, Mich …